Current situation of sporotrichosis in China
- PMID: 39056139
- PMCID: PMC11323943
- DOI: 10.1080/17460913.2024.2352283
Current situation of sporotrichosis in China
Abstract
Sporotrichosis, a mycosis resulting from cutaneous or subcutaneous infection with the dimorphic fungus Sporothrix, has been reported in China, particularly in the northeast region. In this review, we conducted a thorough examination of the recent advancements in sporotrichosis in China, encompassing aspects such as etiology, epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment strategies. Within the Chinese context, fixed cutaneous sporotrichosis represents the prevailing clinical manifestation. Fungal culture stands as the gold standard for diagnosing sporotrichosis, while polymerase chain reaction techniques can enhance both the specificity and sensitivity of diagnosis. Besides conventional systemic antifungal agents, alternative modalities such as Chinese herbal medicines, photodynamic therapy and laser therapy show potential efficacy against sporotrichosis.
Keywords: China; Sporothrix globosa; antimicrobial peptide; photodynamic therapy; sporotrichosis; virulence.
Plain language summary
Sporotrichosis is a fungal infection on the skin. It is caused by a group of fungi called Sporothrix. Common symptoms are lesions on the skin, inflammatory papules, nodules and ulcers. These fungi live in the natural environment and cause infection by entering the body through a wound in the skin. China has a high prevalence of sporotrichosis, with northeast China the most seriously affected region. This review looks at the state of sporotrichosis in China.
Conflict of interest statement
The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Figures

Similar articles
-
Sporotrichosis co-infection with human immunodeficiency virus/acquired immunodeficiency syndrome.Mycoses. 2023 Oct;66(10):845-853. doi: 10.1111/myc.13627. Epub 2023 Jun 28. Mycoses. 2023. PMID: 37376902
-
Systematic review of literature to evaluate global distribution of species of the Sporothrix genus stored in culture collections.Front Cell Infect Microbiol. 2024 May 17;14:1382508. doi: 10.3389/fcimb.2024.1382508. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38828263 Free PMC article.
-
Drug to genome to drug: a computational large-scale chemogenomics screening for novel drug candidates against sporotrichosis.Braz J Microbiol. 2024 Sep;55(3):2655-2667. doi: 10.1007/s42770-024-01406-x. Epub 2024 Jun 18. Braz J Microbiol. 2024. PMID: 38888692 Free PMC article.
-
Cat-transmitted sporotrichosis by Sporothrix brasiliensis: Focus on its potential transmission routes and epidemiological profile.Med Mycol. 2025 Jun 5;63(6):myaf051. doi: 10.1093/mmy/myaf051. Med Mycol. 2025. PMID: 40489322
-
A novel approach for feline sporotrichosis pathogen detection based on loop-mediated isothermal amplification.Vet Dermatol. 2025 Aug;36(4):474-484. doi: 10.1111/vde.13345. Epub 2025 Apr 21. Vet Dermatol. 2025. PMID: 40259669 Free PMC article.
Cited by
-
An Outbreak of Sporotrichosis Associated With Tying Crabs.JAMA Dermatol. 2025 Jul 2:e251884. doi: 10.1001/jamadermatol.2025.1884. Online ahead of print. JAMA Dermatol. 2025. PMID: 40601347
References
-
- Huang Huaiqiu. Re-understanding of sporotrichosis and its pathogenic fungi [The reviews of sporotrichosis and the Sporothrix complex]. J Sun Yat-sen Univ. 2021;42(05):641–650.
-
- Miao Mengyu, Bao Fangfang, Zhang Yong, et al. Clinical and drug sensitivity analysis of 119 cases of sporotrichosis [Clinical and drug sensitivity analysis of 119 cases of sporotrichosis]. J Clin Dermatol. 2022;51(06):325–330. doi: 10.16761/j.cnki.1000-4963.2022.06.003 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources